Gladstone Institutional Advisory LLC Myovant Sciences Ltd. Transaction History

Gladstone Institutional Advisory LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$11.38 - $16.4 $170,700 - $245,999	-15,000 Closed	0 $0
Q2 2021 Jan 27, 2023	SELL	$17.07 - $24.56 $3,414 - $4,912	-200 Reduced 1.32%	15,000 $342,000
Q2 2021 Aug 13, 2021	SELL	$17.07 - $24.56 $3,414 - $4,912	-200 Reduced 1.32%	15,000 $342,000
Q1 2021 Jan 27, 2023	BUY	$20.46 - $25.18 $310,992 - $382,736	15,200 New	15,200 $313,000
Q1 2021 May 17, 2021	BUY	$20.46 - $25.18 $310,992 - $382,736	15,200 New	15,200 $313,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.